Must all psychologists study psychopharmacology?

Professional Psychology: Research and Practice

Volumn 31, Issue 6, 2000, Pages 619-627

  Barnett, Jeffrey E ^a,b   Neel, Monica L ^b  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0034338345     PISSN: 07357028     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7028.31.6.619     Document Type: Article

References (68)

1. Adams, K. A., & Bieliauskas, L. A. (1994). Could versus should: A reply to Sammons. Journal of Clinical Psychology in Medical Settings, 1, 209-215.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. American Psychological Association. (1992). Ethical principles of psychologists and code of conduct. American Psychologist, 47, 1597-1611.
4. Antonuccio, D. O., Danton, W. G., & DeNelsky, G. Y. (1995). Psychotherapy versus medication for depression: Challenging the conventional wisdom with data. Professional Psychology: Research and Practice, 26, 574-585.
5. Barkley, R. A., Conners, C. K., Barclay, A., Gadow, K., Gittelman, R., Sprague, R. L., & Swanson, J. (1990). Task force report: The appropriate role of clinical child psychologists in the prescribing of psychoactive medication for children. Journal of Clinical Child Psychology, 19(Suppl.), 1-38.
6. Bascue, L. O., & Zlotowski, M. (1981). Psychologists' attitudes about prescribing medications. Psychological Reports, 48, 645-646.
7. Bell, P. F., Digman, R. H., & McKenna, J. P. (1995). Should psychologists obtain prescribing privileges? A survey of family physicians. Professional Psychology: Research and Practice, 26, 371-376.
8. Benowitz, N. L. (1988). Pharmacologic aspects of cigarette smoking and nicotine addiction. New England Journal of Medicine, 319, 1318-1330.
9. Benowitz, N. L. (1990). Clinical pharmacology of caffeine. Annual Review of Medicine, 41, 277-288.
10. Bernstein, J. G. (1995). Drug therapy in psychiatry (3rd ed.). Baltimore, MD: Mosby.
11. Bray, J. H. (1995). Collaboration with primary care health providers. The Independent Practitioner, 15, 82.
12. Brown, T. M., Skop, B. P., & Mareth, T. R. (1996). Pathophysiology and management of the serotonin syndrome. Annals of Pharmacotherapy, 30, 527-533.
13. Brown, T. M., & Stoudemire, A. (1998). Psychiatric side effects of prescription and over-the-counter medications: Recognition and management. Washington, DC: American Psychiatric Press.
14. Buelow, G. D., & Chafetz, M. D. (1996). Proposed ethical practice guidelines for clinical pharmacopsychology: Sharpening a new focus in psychology. Professional Psychology: Research and Practice, 27, 53-58.
15. Buie, J. (1988, June). Practice priorities: Medicare amendments, hospital privileges, HMO reforms, prescription privileges. APA Monitor, pp. 1, 14-15.
16. Butz, M. R. (1994). Psychopharmacology: Psychology's Jurassic Park? Psychotherapy, 31, 692-699.
17. Cirigliano, M., & Sun, A. (1998). Advising patients about herbal therapies. The Journal of the American Medical Association, 280, 1565-1566.
18. Crenshaw, T. L., & Goldberg, J. P. (1996). Sexual pharmacology: Drugs that affect sexual function. New York: W. W. Norton.
19. DeLeon, P. H. (1988). Public policy and public service: Our professional duty. American Psychologist, 43, 309-315.
20. DeLeon, P. H. (1993). Prescription privileges - evolving progress. The Psychotherapy Bulletin, 28, 7-10.
21. DeLeon, P. H., Bennett, B. E., & Bricklin, P. M. (1997). Ethics and public policy formulation: A case example related to prescription privileges. Professional Psychology: Research and Practice, 28, 518-525.
22. DeLeon, P. H., Fox, R. E., & Graham, S. R. (1991). Prescription privileges: Psychology's next frontier? American Psychologist, 46, 384-393.
23. DeLeon, P. H., & Wiggins, J. G. (1996). Prescription privileges for psychologists. American Psychologist, 51, 225-229.
24. DeNelsky, G. Y. (1991). Prescription privileges for psychologists: The case against. Professional Psychology: Research and Practice, 22, 188-193.
25. Egli, D. (1991). Expanded psychological practice committee. The Independent Practitioner, 11(4), 21-23.
26. Eisenberg, D. M. (1997). Advising patients who seek alternative medical therapies. Annals of Internal Medicine, 127, 61-69.
27. Eisenberg, D. M., Davis, R. B., Ettner, S. L., Appel, S., Wilkey, S., Van Rompay, M., & Kessler, R. C. (1998). Trends in alternative medicine use in the United States, 1990-1997. The Journal of the American Medical Association, 280, 1569-1575.
28. Ernst, E. (1998). Harmless herbs? A review of the recent literature. American Journal of Medicine, 104, 170-178.
29. Fontanarosa, P. B., & Lundberg, G. D. (1998). Alternative medicine meets science. The Journal of the American Medical Association, 280, 1618-1619.
30. Fox, R. E. (1988). Prescribing privileges: Their implications for the practice of psychology. Psychotherapy, 25, 501-507.
31. Frank, R. G. (1992). Prescription privileges for psychologists: Now is the time. Physical Medicine and Rehabilitation: State of the Art Reviews, 6, 577-585.
32. Gelenberg, A. J., & Keith, S. (1997). Psychoses. In A. J. Gelenberg & E. L. Bassuk (Eds.), The practitioner's guide to psychoactive drugs (4th ed., pp. 153-212). New York: Plenum.
33. Greden, J. F. (1981). Caffeinism and caffeine withdrawal. In J. H. Lowinson & P. Ruiz (Eds.), Substance abuse: Clinical problems and perspectives (pp. 274-286). Baltimore: Williams & Wilkins.
34. Grush, L. R., Nierenberg, A., Keefe, B., & Cohen, L. S. (1998). St. John's Wort during pregnancy. The Journal of the American Medical Association, 280, 1566.
35. Hood v. Phillips, 537 S.W.2d 291 (Tex. Civ. App. 1976).
36. Hughes, J. R., Hatsukami, D. K., Mitchell, J. E., & Dahlgren, B. A. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143, 993-997.
37. Hughes, J. R., Higgins, S. T., Bickel, W. K., Hunt, W. K., Fenwick, J. W., Gulliver, S. B., & Mireault, G. C. (1991). Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Archives of General Psychiatry, 48, 611-617.
38. James, J. E. (1991). Caffeine and health. New York: Academic Press.
39. Klerman, G. L. (1990). The psychiatric patient's right to effective treatment: Implications of Osheroff v. Chestnut Lodge. American Journal of Psychiatry, 147, 409-418.
40. Larson, C. A., & Carey, K. B. (1998). Caffeine: Brewing trouble in mental health settings? Professional Psychology: Research and Practice, 29, 373-376.
41. Litrell, J., & Ashford, J. B. (1995). Is it proper for psychologists to discuss medications with clients? Professional Psychology: Research and Practice, 26, 238-244.
42. Marra, T. (1994, February 20). Should clinical psychologists have prescription privileges in California? Psychiatric Times, 3, 20.
43. Meyer, J. D., & Fink, C. M. (1989). Psychiatric symptoms from prescription medications. Professional Psychology: Research and Practice, 20, 90-96.
44. Moyer, D. M. (1995). An opposing view on prescription privileges for psychologists. Professional Psychology: Research and Practice, 26, 586-590.
45. Neel, M. L., & Barnett, J. E. (1998). Should all psychologists study psychopharmacology? The Maryland Psychologist, 44(1), 23-24.
46. Osheroff v. Chestnut Lodge Inc. et al., 490 A.2d 720-724, Md. App., April 10, 1985. N01016 September term 1984.
47. Pace, T. M., Chaney, J. M., Mullins, L. L., & Olson, R. A. (1995). Psychological consultation with primary care physicians: Obstacles and opportunities in the medical setting. Professional Psychology: Research and Practice, 26, 123-131.
48. Packman, W. L., Cabot, M. G., & Bongar, B. (1994). Malpractice arising from negligent psychotherapy: Ethical, legal, and clinical implications of Osheroff v. Chestnut Lodge. Ethics and Behavior, 4, 175-197.
49. Pagliaro, L. A., & Pagliaro, A. M. (1998). Psychologists' psychotropic drug reference. New York: Brunner/Manzel.
50. Physicians' desk reference (53rd ed.). (1999). Montvale, NJ: Medical Economics Company.
51. Physicians' desk reference for herbal medicines. (1999). Montvale, NJ: Medical Economics Company.
52. Physicians' desk reference for nonprescription drugs. (1997). Montvale, NJ: Medical Economics Company.
53. Physicians' desk reference guide to drug interactions, side effects, indications, contraindications. (1997). Montvale, NJ: Medical Economics Company.
54. Pimental, P. A., Stout, C. E., Hoover, M. C., & Kamen, G. B. (1997). Changing psychologists' opinions about prescriptive authority: A little information goes a long way. Professional Psychology: Research and Practice, 28, 123-127.
55. Preston, J. D., O'Neal, J. H., & Talaga, M. C. (1998). Consumer's guide to psychiatric drugs. Oakland, CA: New Harbinger.
56. Quinn, D. I., & Day, R. O. (1995). Drug interactions of clinical importance: An updated guide. Drug Safety, 12, 393-452.
57. Reynolds, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., Pollock, B. G., & Kupfer, D. J. (1999). Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. The Journal of the American Medical Association, 281, 39-45.
58. Rivas-Vazquez, R. A., & Blais, M. A. (1997). Selective serotonin reuptake inhibitors and atypical antidepressants: A review and update for psychologists. Professional Psychology: Research and Practice, 28, 526-536.
59. Sammons, M. T. (1998a). The case for prescription privileges for psychologists: An overview. In S. C. Hayes & E. M. Heiby (Eds.), Prescription privileges for psychologists: The case in favor (pp. 11-46). Reno, NV: Context Press.
60. Sammons, M. T. (1998b, June). Psychopharmacology for psychologists: Clinical update. Continuing education workshop presented to the Maryland Psychological Association. Columbia, MD.
61. Smyer, M. A., Balster, R. L., Egli, D., Johnson, D. L., Kilbey, M. M., Leith, N. J., & Puente, A. E. (1993). Summary of the report of the ad hoc task force on psychopharmacology of the American Psychological Association. Professional Psychology: Research and Practice, 24, 394-403.
62. Sommers-Flanagan, J., & Sommers-Flanagan, R. (1996). Efficacy of anti-depressant medication with depressed youth: What psychologists should know. Professional Psychology: Research and Practice, 27, 145-153.
63. Sternbach, H. (1991). The serotonin syndrome. American Journal of Psychiatry, 148, 705-713.
64. Tatman, S. M., Peters, D. B., Greene, A. L., & Bongar, B. (1997). Graduate students' attitudes toward prescription privileges training. Professional Psychology: Research and Practice, 28, 515-517.
65. Thompson, A. (1990). Guide to ethical practice in psychotherapy. New York: Wiley.
66. Weiner, B. A., & Wettstein, R. M. (1993). Legal issues in mental health care. New York: Plenum Press.
67. Wiggins, J. G. (1992). The case for prescription privileges for psychologists. Psychotherapy in Private Practice, 11, 3-8.
68. Wiggins, J. G., & Cummings, N. A. (1998). National study of the experience of psychologists with psychotropic medication and psychotherapy. Professional Psychology: Research and Practice, 29, 549-552.